Regulation of the Wip1 phosphatase and its effects on the stress response.
- Authors
- Lowe, Julie; Cha, Hyukjin; Lee, Mi-Ok; Mazur, Sharlyn J; Appella, Ettore; Fornace, Albert J
- Year
- 2012
- Journal
- Frontiers in bioscience (Landmark edition)
- PMID
- 22201816
- DOI
- 10.2741/3999
- PMCID
- PMC3508688
Wip1 (PPM1D) is a stress responsive PP2C phosphatase that plays a key role in stress signaling. Although originally identified as a gene induced by p53 after genotoxic stress, we now know that Wip1 expression is additionally regulated by other mechanisms. Wip1 is not only a target of p53, but is also a target of other transcription factors, including Estrogen Receptor-alpha and NF-kappaB. Additionally, Wip1 expression is regulated by post-transcriptional mechanisms such as mRNA stabilization and alternative splicing. Upon induction, Wip1 dampens the stress response by dephosphorylating and inactivating proteins such as p53, p38 MAPK, and ATM, usually as part of a negative feedback loop. As a result, Wip1 functions to abrogate cell cycle checkpoints and inhibit senescence, apoptosis, DNA repair, and the production of inflammatory cytokines. Furthermore, Wip1 is overexpressed in several types of human cancers and has oncogenic functions. The regulation of Wip1, the role of Wip1 in stress signaling, and the cooperation of Wip1 with oncogenes in promoting tumorigenesis will be discussed in this review.
Transcription factor binding sites in the PPM1D promoter. A schematic of the PPM1D promoter region shows the location of the transcription factor binding sites (based on the NCBI March 2006 human reference sequence Build 36.1). A list of the transcription factors and the location and the sequence of the respective binding site is shown.
Transcriptional regulation of PPM1D. The currently known transcription factors that enhance PPM1D transcription are p53, CREB, E2F1, c-jun, ERalpha, and NF-kappaB. The regulation by each of these factors depends on context, namely the type of stress and possibly the tissue type (see text for details).
Regulation of Wip1 expression: emphasis on post-transcriptional mechanisms. The four mechanisms of post-transcriptional modulation of Wip1 expression are depicted. After DNA damage, BRCA1-IRIS enhances the expression of HuR, which stabilizes Wip1 mRNA leading to enhanced Wip1 expression. IR-induced miR-16 destabilizes Wip1 mRNA and decreases Wip1 expression. The Wip1 transcript is alternatively spliced to form a shorter variant (βPPM1D430β), which leads to an enhanced expression of a smaller Wip1 protein (βWip1sβ) that localizes to the nucleus, cytoplasm and plasma membrane. IR induces a p53-dependent shift in the transcriptional start site (βTSSβ) of PPM1D, which produces a shorter transcript allowing for more efficient export from the nucleus.
The targets and functional consequences of Wip1 signaling. Wip1 signals through direct dephosphorylation of target proteins, which prevents apoptosis, inhibits DNA repair, reverses cell cycle arrest, and reduces inflammation. The proteins highlighted in red suppress tumorigenesis, and Wip1 inhibition of these proteins promotes tumorigenesis. *p53 and p38 MAPK enhance the tumor suppressor effects of p16Ink4a/p19Arf.
Model of stem cell self-renewal under normal and cancerous conditions. Stem cells normally remain quiescent due to strong anti-growth control from their surrounding microenvironment, termed a niche. A transient proliferation signal stimulates self-renewal to support tissue regeneration. Maintenance of stemness is promoted by Wip1. Under cancerous conditions, internal mutations and alteration of the microenvironment promote abnormal self-renewal of stem cells favoring growth. Unless tumor suppressors detect such an abnormality, cancerous stem cells (CSCs) or cancer initiating cells (TICs) may be generated from stem cells after a secondary genetic mutation. The proliferation of CSCs or TICs may be promoted by overexpression of Wip1.
Wip1 negative feedback in inflammatory signaling. Schematic adapted from (6). Wip1 expression is induced by NF-kappaB. Wip1 inhibits production of TNFalpha by dephosphorylating and inhibiting the NF-kappaB subunit p65 (highlighted in green) and inhibits IL-6 and IL-8 production through p38 MAPK (highlighted in purple).
| # | Section | Preview |
|---|---|---|
| 40 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.3. Wip1 and the UV response β 4.3.2. Wip1 dampens the UV response β 4.3.2.2. Dampening of the DDR | Although not directly produced by UV radiation exposure, DSBs can be formed indirectly through, forβ¦ |
| 41 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.3. Wip1 and the UV response β 4.3.2. Wip1 dampens the UV response β 4.3.2.2. Dampening of the DDR | 24 hours after UV radiation exposure when Wip1 expression was high. However, these foci persisted inβ¦ |
| 42 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.1. Inhibition of apoptosis | Apoptosis, or programmed cell death, ensures that injured cells do not replicate and pass on genomicβ¦ |
| 43 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.1. Inhibition of apoptosis | p53-dependent apoptosis is well characterized and involves numerous signaling proteins to induce theβ¦ |
| 44 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.1. Inhibition of apoptosis | correlated with higher levels of activated p53, thus demonstrating that Wip1 inhibits intestinalβ¦ |
| 45 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.1. Inhibition of apoptosis | The inhibition of apoptosis by Wip1 also reflects its negative feedback on the p38 MAPK/p53 pathway.β¦ |
| 46 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.1. Inhibition of apoptosis | Wip1 also inhibits E2F1-induced and UV radiation-induced apoptosis, presumably through p38 MAPK (32,β¦ |
| 47 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.1. Inhibition of apoptosis | The effect of Wip1 over-expression on Chk2-dependent apoptosis has also been examined. Chk1 and Chk2β¦ |
| 48 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.1. Inhibition of apoptosis | Finally, Xia et al. showed that Wip1 not only protects from DNA damage-induced apoptosis, but alsoβ¦ |
| 49 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.2. Recovery and rescue from cell cycle arrest | Like apoptosis, cell cycle arrest is critical in preventing DNA replication of a damaged genome.β¦ |
| 50 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.2. Recovery and rescue from cell cycle arrest | of signaling important for the maintenance, and not initiation, of the G1 checkpoint (through p53β¦ |
| 51 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.2. Recovery and rescue from cell cycle arrest | More recently, Lindqvist et al. showed that Wip1 is required for G2 checkpoint recovery competenceβ¦ |
| 52 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.2. Recovery and rescue from cell cycle arrest | type cells, Wip1-depleted HCT116 p53β/β cells were able to recover from G2 arrest, indicatingβ¦ |
| 53 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.3. Function of Wip1 in stem cells | Adult stem cells act as a reservoir for the regeneration of damaged tissue. These stem cellsβ¦ |
| 54 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.3. Function of Wip1 in stem cells | recent studies have revealed that the reduced proliferative potential of stem cells and theβ¦ |
| 55 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.3. Function of Wip1 in stem cells | Recently, Wip1 was found to be expressed in intestinal stem cells and to inhibit p53-mediatedβ¦ |
| 56 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.3. Function of Wip1 in stem cells | hand, human mesenchymal stem cells (hMSCs) undergo premature senescence in culture due toβ¦ |
| 57 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.3. Function of Wip1 in stem cells | Dysregulation of Wip1 signaling may also play a role in aging. Wip1 expression is significantlyβ¦ |
| 58 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.4. Inhibition of inflammation | Analysis of the phenotype of Wip1β/β mice provided the first clue that Wip1 may play a role inβ¦ |
| 59 | 4. WIP1 SUPPRESSES THE STRESS RESPONSE: UPDATE β 4.4. Functional consequences of Wip1 after stress β 4.4.4. Inhibition of inflammation | activity by Wip1 is presumed to occur through dephosphorylation of T180 of p38, its previouslyβ¦ |
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| DSM-5 cannabis use disorder: a phenotypic and genomic perspective. | 2014 | 24315570 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| CEP-1347 Boosts Chk2-Mediated p53 Activation by Ionizing Radiation to Inhibit the Growth of Malignant Brain Tumor Cells. | Mitobe Y et al. | β | 2024 | β |
| PP2C phosphatases-terminators of suicidal thoughts. | Lagorgette L et al. | β | 2024 | β |
| PPM1D/Wip1 is amplified, overexpressed, and mutated in human non-Hodgkin's lymphomas. | Pilevneli H et al. | β | 2024 | β |
| Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders. | Liu X et al. | β | 2024 | β |
| Clonal haematopoiesis - a novel entity that modifies pathological processes in elderly. | Belotserkovskaya E et al. | β | 2023 | β |
| Radiotherapy and radio-sensitization in H3<sup>K27M</sup> -mutated diffuse midline gliomas. | Liu C et al. | β | 2023 | β |
| Construction of the axolotl cell landscape using combinatorial hybridization sequencing at single-cell resolution. | Ye F et al. | β | 2022 | β |
| High expression of uracil DNA glycosylase determines C to T substitution in human pluripotent stem cells. | Park JC et al. | β | 2022 | β |
| Low WIP1 Expression Accelerates Ovarian Aging by Promoting Follicular Atresia and Primordial Follicle Activation. | Zhou S et al. | β | 2022 | β |
| Mitogen Activated Protein Kinase (MAPK) Activation, p53, and Autophagy Inhibition Characterize the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein Induced Neurotoxicity. | Kyriakopoulos AM et al. | β | 2022 | β |
| p53 as a biomarker and potential target in gastrointestinal stromal tumors. | Wu CE et al. | β | 2022 | β |
| PPM1D in Solid and Hematologic Malignancies: Friend and Foe? | Zhang L et al. | β | 2022 | β |
| Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery. | Elhassan RM et al. | β | 2022 | β |
| Metal dependent protein phosphatase PPM family in cardiac health and diseases. | Gao C et al. | β | 2021 | β |
| Oncogenic WIP1 phosphatase attenuates the DNA damage response and sensitizes p53 mutant Jurkat cells to apoptosis. | Eren MK et al. | β | 2021 | β |
| Protein phosphatases in TLR signaling. | Seumen CHT et al. | β | 2021 | β |
| Tipping Growth Inhibition into Apoptosis by Combining Treatment with MDM2 and WIP1 Inhibitors in p53<sup>WT</sup> Uterine Leiomyosarcoma. | Chamberlain V et al. | β | 2021 | β |
| The biological function and the regulatory roles of wild-type p53-induced phosphatase 1 in immune system. | Shi L et al. | β | 2020 | β |
| WIP1 dephosphorylation of p27<sup>Kip1</sup> Serine 140 destabilizes p27<sup>Kip1</sup> and reverses anti-proliferative effects of ATM phosphorylation. | Choi BK et al. | β | 2020 | β |
| Wip1 phosphatase deficiency impairs spatial learning and memory. | Liu SC et al. | β | 2020 | β |
| Wip1 regulates Smad4 phosphorylation and inhibits TGF-Ξ² signaling. | Park DS et al. | β | 2020 | β |
| Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma. | Akamandisa MP et al. | β | 2019 | β |
| Redox activation of JNK2Ξ±2 mediates thyroid hormone-stimulated proliferation of neonatal murine cardiomyocytes. | Tan L et al. | β | 2019 | β |
| Emerging Roles of Sonic Hedgehog in Adult Neurological Diseases: Neurogenesis and Beyond. | Chen SD et al. | β | 2018 | β |
| Integrating the DNA damage and protein stress responses during cancer development and treatment. | Gorgoulis VG et al. | β | 2018 | β |
| Revealing determinants of two-phase dynamics of P53 network under gamma irradiation based on a reduced 2D relaxation oscillator model. | DemirkΔ±ran G et al. | β | 2018 | β |
| Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma. | Wu CE et al. | β | 2018 | β |
| Two-dimensional polynomial type canonical relaxation oscillator model for p53 dynamics. | DemirkΔ±ran G et al. | β | 2018 | β |
| WIP1 phosphatase suppresses the DNA damage response during G2/prophase arrest in mouse oocytes. | Leem J et al. | β | 2018 | β |
| Wip1 regulates blood-brain barrier function and neuro-inflammation induced by lipopolysaccharide via the sonic hedgehog signaling signaling pathway. | Zhen H et al. | β | 2018 | β |
| Expression of wild-type p53-induced phosphatase 1 in diabetic epiretinal membranes. | Xu J et al. | β | 2017 | β |
| Interaction of Wip1 and NF-ΞΊB regulates neuroinflammatory response in astrocytes. | Xu F et al. | β | 2017 | β |
| LZAP is a novel Wip1 binding partner and positive regulator of its phosphatase activity in vitro. | Wamsley JJ et al. | β | 2017 | β |
| Role of wild-type p53-induced phosphatase 1 in cancer. | Wang ZP et al. | β | 2017 | β |
| The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppression. | Lowe JM et al. | β | 2017 | β |
| Wild-type p53-induced phosphatase 1 is a prognostic marker and therapeutic target in bladder transitional cell carcinoma. | Wang ZP et al. | β | 2017 | β |
| Wip1: A candidate phosphatase for cancer diagnosis and treatment. | Oghabi Bakhshaiesh T et al. | β | 2017 | β |
| Wip1 directly dephosphorylates NLK and increases Wnt activity during germ cell development. | Cho SJ et al. | β | 2017 | β |
| WIP1 phosphatase is a critical regulator of adipogenesis through dephosphorylating PPARΞ³ serine 112. | Li D et al. | β | 2017 | β |
| Wip1 regulates SKOV3 cell apoptosis through the p38 MAPK signaling pathway. | Feng Y et al. | β | 2017 | β |
| Chemical Inhibition of Wild-Type p53-Induced Phosphatase 1 (WIP1/PPM1D) by GSK2830371 Potentiates the Sensitivity to MDM2 Inhibitors in a p53-Dependent Manner. | Esfandiari A et al. | β | 2016 | β |
| Cisplatin induces HepG2 cell cycle arrest through targeting specific long noncoding RNAs and the p53 signaling pathway. | Wang P et al. | β | 2016 | β |
| Control of stress signaling in stem cells: crossroads of stem cells and cancer. | Cho SJ et al. | β | 2016 | β |
| Gamma-H2AX upregulation caused by Wip1 deficiency increases depression-related cellular senescence in hippocampus. | He ZY et al. | β | 2016 | β |
| Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma. | Cinegaglia NC et al. | β | 2016 | β |
| Plant protein phosphatases 2C: from genomic diversity to functional multiplicity and importance in stress management. | Singh A et al. | β | 2016 | β |
| PPM1D exerts its oncogenic properties in human pancreatic cancer through multiple mechanisms. | Wu B et al. | β | 2016 | β |
| Protein phosphatase magnesium-dependent 1Ξ΄ is a novel tumor marker and target in hepatocellular carcinoma. | Xu Z et al. | β | 2016 | β |
| Up-regulation of Wip1 involves in neuroinflammation of retinal astrocytes after optic nerve crush via NF-ΞΊB signaling pathway. | Zhong H et al. | β | 2016 | β |
| Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis. | Chen Z et al. | β | 2016 | β |
| Wip1 phosphatase modulates both long-term potentiation and long-term depression through the dephosphorylation of CaMKII. | He ZY et al. | β | 2016 | β |
| A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1. | Wang B et al. | β | 2015 | β |
| Mice deficient for wild-type p53-induced phosphatase 1 display elevated anxiety- and depression-like behaviors. | Ruan CS et al. | β | 2015 | β |
| SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of "cancer cells with neural stemness" in a p53-dependent manner. | Lee JS et al. | β | 2015 | β |
| Timely Degradation of Wip1 Phosphatase by APC/C Activator Protein Cdh1 is Necessary for Normal Mitotic Progression. | Jeong HC et al. | β | 2015 | β |
| Wip1 deficiency impairs haematopoietic stem cell function via p53 and mTORC1 pathways. | Chen Z et al. | β | 2015 | β |
| Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction. | Gilmartin AG et al. | β | 2014 | β |
| DSM-5 cannabis use disorder: a phenotypic and genomic perspective. | Agrawal A et al. | β | 2014 | β |
| Off-target response of a Wip1 chemical inhibitor in skin keratinocytes. | Lee JS et al. | β | 2014 | β |
| Phosphatase Wip1 as a new therapeutic target for intestinal ischemia-reperfusion injury. | Shen X et al. | β | 2014 | β |
| Targeting PPM1D by lentivirus-mediated RNA interference inhibits the tumorigenicity of bladder cancer cells. | Wang W et al. | β | 2014 | β |
| Wild-type p53-induced phosphatase 1 (Wip1) forestalls cellular premature senescence at physiological oxygen levels by regulating DNA damage response signaling during DNA replication. | Sakai H et al. | β | 2014 | β |
| Wip1 abrogation decreases intestinal tumor frequency in APC(Min/+) mice irrespective of radiation quality. | Suman S et al. | β | 2014 | β |
| WIP1 and senescence: oxygen matters. | Olcina MM et al. | β | 2014 | β |
| WIP1 regulates the proliferation and invasion of nasopharyngeal carcinoma in vitro. | Zhang Y et al. | β | 2014 | β |
| Binding of a third metal ion by the human phosphatases PP2CΞ± and Wip1 is required for phosphatase activity. | Tanoue K et al. | β | 2013 | β |
| Down-regulation of wild-type p53-induced phosphatase 1 (Wip1) plays a critical role in regulating several p53-dependent functions in premature senescent tumor cells. | Crescenzi E et al. | β | 2013 | β |
| The accumulation of DNA repair defects is the molecular origin of carcinogenesis. | Cha HJ et al. | β | 2013 | β |
| The modulation of the oxidative stress response in chondrocytes by Wip1 and its effect on senescence and dedifferentiation during in vitro expansion. | Cha BH et al. | β | 2013 | β |
| The protein p17 signaling pathways in cancer. | Heese K | β | 2013 | β |
| WIP1, a homeostatic regulator of the DNA damage response, is targeted by HIPK2 for phosphorylation and degradation. | Choi DW et al. | β | 2013 | β |
| Wip1 downregulation conserves truncated DNA damage response (DDR) in mitosis. | Vaz B et al. | β | 2013 | β |
| Wip1 phosphatase involved in lipopolysaccharide-induced neuroinflammation. | Tan X et al. | β | 2013 | β |
| Wip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax/Bcl-xL ratio. | Goloudina AR et al. | β | 2012 | β |